Login to Your Account

Pharma: Other News To Note

Wednesday, April 24, 2013
Sucampo Pharmaceuticals Inc., of Bethesda, Md., said the FDA approved its prostone-based therapy Amitiza (lubiprostone) as the first oral treatment of opioid-induced constipation (OIC) in patients with chronic, noncancer pain.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription